Latest Center News
Explore the Center’s latest research, publications, events, funding opportunities, and community outreach.
The Cornell Center for Enervating NeuroImmune Disease is accepting pilot funding proposals to advance ME/CFS research. Eligible Cornell Ithaca-campus investigators, including graduate students and postdoctoral researchers, may apply by 5 p.m. ET on October 8, 2026....
A talk from Dr. Maureen Hanson, Center Director, is now available on YouTube as part of Action for ME's PRIME webinar series. In her presentation, "Molecular Signals of...
Center investigators recently participated in the Invest in ME Research 2026 conference week at the Wellcome Genome Campus in Cambridge, UK, attending both the 15th...
Our Center Director, Dr. Maureen Hanson, recently visited the WE&ME Foundation in Vienna, Austria, in her role as a member of their Scientific Advisory Board. During...
Graphical abstract by Arnaud Germain, Ph.D. Post-exertional malaise (PEM) is the hallmark symptom of ME/CFS: an exacerbation of symptoms triggered by physical or...
Anne Gardella, a graduate student researcher in the Cornell Center for Enervating NeuroImmune Disease, has been awarded the Research Insight prize at the 2025 ME...
A recent study identified epigenetic changes in immune cells that may help explain biological differences in people with ME/CFS. The findings point to potential biomarkers and underscore the need for additional research....
We’re excited to share that a graduate student within the Center, Anne Gardella, has been featured in Discover Magazine for her recent publication in the Proceedings of the National Academy of Sciences on cell-free RNA biomarkers for ME/CFS....
Great work by Center member and lead author Anne Gardella (doctoral student, De Vlaminck Lab) on demonstrating how cell-free RNA (cfRNA) in blood could help us...
Researchers from the Center for Enervating Neuroimmune Disease have published a new study investigating extracellular vesicle (EV) proteins in ME/CFS. The research,...
Researchers from the Cornell Center for Enervating Neuroimmune Disease, Fred Hutchinson Cancer Center, Yale School of Medicine, and Augmenta Bioworks have published a...
